Mahindra Manulife Innovation Opp Fund
The Scheme shall seek to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies following innovation theme.
Growthvine rating: 1/5 — ranked #164 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹10.10 (as of 2026-10-22) |
|---|
| AUM | ₹257 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Renjith Sivaram Radhakrishnan |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −10.55% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 40.1% |
|---|
| Mid cap | 34.9% |
|---|
| Small cap | 24.9% |
|---|
Concentration
| Top 5 holdings | 14.4% |
|---|
| Top 10 holdings | 26.8% |
|---|
| Total holdings | 54 |
|---|
Top holdings
- Eternal Limited — 3.8%
- Bajaj Finance Limited — 2.7%
- One 97 Communications Limited — 2.6%
- ICICI Bank Ltd. — 2.6%
- Aditya Birla Capital Ltd — 2.6%
- ACUTAAS CHEMICALS LIMITED — 2.6%
- Torrent Pharmaceuticals Ltd. — 2.6%
- Reliance Industries Ltd — 2.5%
- BELRISE INDUSTRIES LIMITED — 2.4%
- Triparty Repo — 2.3%
Top sectors
- Pharma & Biotech — 13.1%
- Banking & Financial — 10.1%
- Finance & Investments — 6.7%
Calendar-year track record
No calendar-year history.